Boston Scientific (BSX) - Stock Price & Dividends

Exchange: USA Stocks • Country: United States • Currency: USD • Type: Common Stock • ISIN: US1011371077

Boston Scientific Corporation, listed on the NYSE under the symbol BSX, is a global leader in the development, manufacturing, and distribution of medical devices across various medical specialties worldwide.

The company operates through two primary segments: MedSurg and Cardiovascular. Boston Scientific offers a wide range of devices designed to diagnose and treat conditions affecting the gastrointestinal, pulmonary, urological, pelvic, and cardiac systems. These include implantable cardioverter defibrillators, pacemakers, remote patient management systems, and more.

Moreover, Boston Scientific provides cutting-edge medical technologies for diagnosing and treating heart rate and rhythm disorders, such as cardiac mapping solutions, ablation catheters, spinal cord stimulator systems, and deep brain stimulation systems.

In the field of interventional cardiology, the company offers products to address coronary artery disease and aortic valve conditions. This includes stents, balloon catheters, guidewires, as well as atherectomy and thrombectomy systems to treat arterial and venous diseases.

Founded in 1979 and headquartered in Marlborough, Massachusetts, Boston Scientific continues to drive innovation in the healthcare industry with a commitment to improving patient outcomes. For more information, visit their website at https://www.bostonscientific.com.

Drawdown (Underwater) Chart

Drawdown / Underwater Chart for Boston Scientific (BSX) - Stock Price & Dividends

Overall Trend and Yearly Seasonality

Drawdown / Underwater Chart for Boston Scientific (BSX) - Stock Price & Dividends

BSX Stock Overview

Market Cap in USD 99,101m
Sector Healthcare
Industry Medical Devices
GiC SubIndustry Health Care Equipment
TER 0.00%
IPO / Inception 1992-05-18

BSX Stock Ratings

Growth 5y 7.02
Fundamental 42.0
Dividend -
Rel. Performance vs Sector 2.54
Analysts 4.48/5
Fair Price Momentum 73.16 USD
Fair Price DCF 32.40 USD

BSX Dividends

Yield 12m 0.00%
Yield on Cost 5y 0.00%
Dividends CAGR 5y 0.00%
Payout Consistency 0.0%

BSX Growth Ratios

Growth 12m 42.68%
Growth Correlation 12m 61%
Growth Correlation 3m 75%
CAGR 5y 14.67%
Sharpe Ratio 12m 1.86
Alpha vs SP500 12m 15.06
Beta vs SP500 5y weekly 1.04
ValueRay RSI 93.43
Volatility GJR Garch 1y 19.04%
Price / SMA 50 8.08%
Price / SMA 200 26.19%
Current Volume 15276.5k
Average Volume 20d 6347.5k

External Links for BSX Stock

News
Wall Street JournalBenzingaYahoo Finance
Tweets
X (Twitter)Stocktwits
Fund Manager Positions
DataromaStockcircle
What is the price of BSX stocks?
As of April 25, 2024, the stock is trading at USD 72.91 with a total of 15,276,470 shares traded.
Over the past week, the price has changed by +7.28%, over one month by +8.35%, over three months by +21.68% and over the past year by +42.01%.
What is the forecast for BSX stock price target?
According to ValueRays Forecast Model, BSX Boston Scientific will be worth about 81.3 in April 2025. The stock is currently trading at 72.91. This means that the stock has a potential upside of +11.47%.
Issuer Forecast Upside
Wallstreet Target Price 73.8 1.15
Analysts Target Price 61.2 -16.1
ValueRay Target Price 81.3 11.5

Boston Scientific Corp: Pioneering Medical Solutions

History and Transformation

Boston Scientific Corporation, founded in 1979, has been at the forefront of the medical devices industry. The journey began with its founders, John Abele and Pete Nicholas, who aimed to provide less invasive, more accessible medical solutions. Boston Scientific distinguished itself early on by introducing groundbreaking medical devices, leading the charge towards less invasive medical treatments globally.

Core Business Focus

At its heart, Boston Scientific is dedicated to transforming lives through innovative medical solutions that improve the health of patients around the world. The company excels in various medical areas, including interventional cardiology, rhythm management, endoscopy, neuromodulation, urology and pelvic health, and peripheral interventions. Boston Scientific's commitment to enhancing patient outcomes through less invasive procedures drives its continuous growth and innovation in these areas.

Expanding Horizons: Side Businesses

Beyond its core products, Boston Scientific has diversified into related healthcare services and solutions, broadening its impact. This includes the development of digital health solutions and services designed to improve patient care, drive efficiencies in healthcare delivery, and offer value beyond their core device offerings. Their involvement in healthcare education for professionals, alongside investments in research and development, signifies a broad-based approach to changing the face of medicine.

Current Market Status

As of the latest market analyses, Boston Scientific Corporation (NYSE:BSX) remains a formidable player in the medical devices sector. The company has shown resilience and adaptability, continuously posting strong financial performance despite challenges posed by global economic changes and the healthcare landscape. Its commitment to innovation, coupled with a strategic approach to market challenges and opportunities, positions Boston Scientific well for future growth.